PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Bundeswehr Institute of Microbiology, Neuherbergstraße 11, D-80937 Munich, Germany; German Centre for Infection Research (DZIF), partner site Munich, Germany.\', \'Bundeswehr Institute of Microbiology, Neuherbergstraße 11, D-80937 Munich, Germany; German Centre for Infection Research (DZIF), partner site Munich, Germany. Electronic address: philippgirl@bundeswehr.org.\', \'Institute for Transfusion Medicine and Haemostasis, Medical Faculty, University of Augsburg, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1386-6532(21)00179-710.1016/j.jcv.2021.104912
?:doi
?:hasPublicationType
?:journal
  • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
is ?:pmid of
?:pmid
?:pmid
  • 34298379
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all